What Happened?
Cambridge, MA-based Sigilon Therapeutics Appointed Susan Drapeau as Vice President and Head of Device and Delivery Engineering
About the Company
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.
About the Person
Susan Drapeau is Vice President and Head of Device and Delivery Engineering at Sigilon Therapeutics. Previously, Susan held various senior IT leadership roles in the industry.
Info Source
News
Short Profile